STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation

Our study reveals that interferon-induced STAT1 signaling is a central mediator of both systemic and hepatic inflammation during a TLR9-induced cytokine storm. Based on these findings, we support the therapeutic use of JAK1/2 inhibitors, such as ruxolitinib and baricitinib, which indirectly suppress STAT1 activity, in patients with cytokine storm syndromes and inflammatory liver disorders to alleviate both systemic and hepatic symptoms. Notably, our data also highlight the promise of direct STAT1 inhibition as a more and potentially refined approach for intervention.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-11-06
DOI
https://doi.org/10.1016/j.jhepr.2025.101668
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation

Carine Wouters, Nele Berghmans, Niels Vandamme, Fran Prenen et al.
JHEP Reports
Cytokine Signaling Pathways and Interactions
article

STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation

Carine Wouters, Nele Berghmans, Niels Vandamme, Fran Prenen, Eline Bernaerts, Olivier Govaere, Philippe E. Van den Steen, Bert Malengier‐Devlies, Patrick Matthys, Jarne Beliën, Hanne Meers, Charlotte L. Scott, Jochen Lamote, Anna Bujko, Tania Mitera, Amber De Visscher, Liliana Sokol, Marte Vandeput, Seniye Anak
article en

Abstract

Our study reveals that interferon-induced STAT1 signaling is a central mediator of both systemic and hepatic inflammation during a TLR9-induced cytokine storm. Based on these findings, we support the therapeutic use of JAK1/2 inhibitors, such as ruxolitinib and baricitinib, which indirectly suppress STAT1 activity, in patients with cytokine storm syndromes and inflammatory liver disorders to alleviate both systemic and hepatic symptoms. Notably, our data also highlight the promise of direct STAT1 inhibition as a more and potentially refined approach for intervention.

JHEP ReportsVol. 8(2)
Rega Institute for Medical Research (BE), Ghent University (BE), VIB-KU Leuven Center for Cancer Biology (BE), VIB-KU Leuven Center for Microbiology (BE), MRC Centre for Reproductive Health (GB), VIB-UGent Center for Inflammation Research (BE), VIB-KU Leuven Center for Brain & Disease Research (BE), University of Edinburgh (GB), KU Leuven (BE)
Fonds Wetenschappelijk Onderzoek, KU Leuven, Onderzoeksraad, KU Leuven, Vlaamse regering
Openalex Percentile: Top 55%
Cytokine Signaling Pathways and Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.